Candace Jackson, SVP, General Counsel and Corporate Secretary of Silvaco Group, Inc., filed a Form 4 on November 13, 2026, disclosing a sale of 3,000 shares of Silvaco common stock on November 12, 2026.
Director Lee R. Gibson of Southside Bancshares Inc filed a Form 4 on November 13, 2026, reporting a gift disposition of 3,300 shares of common stock on November 12, 2026, at a price of $0.
David Kwon, a Corporate Vice President at Automatic Data Processing Inc, filed a Form 4 on November 13, 2026, reporting a disposition of 69 shares of common stock on November 12, 2026, via a gift transaction at a price of $0.0000 per share.
Director Douglas A. Suriano filed a Form 4 with the SEC on November 13, 2026, disclosing the sale of 4,000 shares of Bandwidth Inc. Class A Common Stock on November 12, 2026, pursuant to a Rule 10b5-1 plan.
Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte, Inc. (NASDAQ:PCVX), filed a Form 4 on November 13, 2026, disclosing the exercise of stock options and the sale of common stock on November 11, 2026, pursuant to a Rule 10b5-1 trading plan.
Director Bridget A. Martell filed a Form 4 with the SEC on November 13, 2026, disclosing transactions in Delcath Systems, Inc. common stock dated November 12, 2026, including a stock option exercise and two open-market sales.
Director M. Bradley Smith of TPG RE Finance Trust, Inc. filed a Form 4 on November 13, 2026, disclosing two open-market purchases of common stock totaling 10,000 shares made on November 11 and November 12, 2026.
Director Michael Gillmore of TPG RE Finance Trust, Inc. filed a Form 4 on November 13, 2026, disclosing a purchase of 2,500 shares of common stock on November 12, 2026.
Venkataraman Ramaswamy Iyer, President of Resources Connection, Inc., filed a statement of changes in beneficial ownership on November 13, 2026, reporting a tax-withholding disposition of common stock tied to the vesting of restricted stock units on November 12, 2026.
Kendra Adams, Chief Financial Officer of C4 Therapeutics, Inc., filed a Form 4 on November 13, 2026, reporting the sale of 45,173 shares of common stock on November 12, 2026, pursuant to a Rule 10b5-1 trading plan.